| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,098 |
4,547 |
$229K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,541 |
1,341 |
$82K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,029 |
768 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
368 |
302 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
926 |
870 |
$10K |
| 73630 |
|
516 |
488 |
$5K |
| 73610 |
|
359 |
348 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
133 |
133 |
$3K |
| 73110 |
|
176 |
163 |
$2K |
| 73564 |
|
144 |
137 |
$2K |
| 73130 |
|
147 |
139 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
69 |
54 |
$931.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
746 |
572 |
$880.70 |
| 73140 |
|
45 |
40 |
$765.11 |
| 81003 |
|
211 |
207 |
$468.65 |
| 72110 |
|
13 |
12 |
$194.44 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
102 |
68 |
$189.04 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$188.50 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
35 |
28 |
$156.03 |
| 74018 |
|
12 |
12 |
$150.83 |
| 87807 |
|
14 |
14 |
$144.47 |
| 73030 |
|
13 |
13 |
$106.89 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$1.82 |